InvestorsHub Logo

buckiii2

08/18/16 2:53 PM

#18787 RE: buckiii2 #18786

ONTX. Answered my own question. So this puts the OS at about 7m.

Completion of $17.4 Million Oversubscribed Financing

On July 29, 2016, Onconova closed its oversubscribed rights offering. Although the number of units able to be sold was capped at a maximum of 4,256,186 units (or approximately $17.4 million in gross proceeds), there was a total demand for approximately 4.9 million units in the rights offering.
Overall, 4,256,186 units consisting of a total of 3,599,786 shares of common stock, pre-funded warrants to purchase an additional 656,400 shares of common stock, and 3,192,022 tradable warrants were issued in this offering.
Including the net proceeds from the rights offering of approximately $15.8 million, Onconova had cash and cash equivalents of approximately $27.6 million at July 31, 2016.

buckiii2

08/18/16 3:04 PM

#18788 RE: buckiii2 #18786

BRIEF-Tyndall Capital reports 13.5 percent passive stake in Onconova
BY Reuters
— 6:26 AM ET 08/18/2016
Aug 18 (Reuters) - Onconova Therapeutics Inc ( ONTX
Loading...
Loading...
)
* Tyndall Capital Partners LP reports 13.5 percent passive stake in Onconova Therapeutics Inc ( ONTX
Loading...
Loading...
), as of July 29, 2016 - SEC filing Source text for Eikon: Further company coverage:

Item 4. Ownership
(a) Amount Beneficially Owned: 911,456**
(b) Percent of Class: 13.5%**

ash111

08/18/16 3:36 PM

#18790 RE: buckiii2 #18786

i posted current information on $heff board(reply his post),6,340,401 O/S as of August 10, 2016